Filing Details
- Accession Number:
- 0001104659-22-028815
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-01 17:57:48
- Reporting Period:
- 2022-02-28
- Accepted Time:
- 2022-03-01 17:57:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1554859 | Semler Scientific Inc. | SMLR | Electromedical & Electrotherapeutic Apparatus (3845) | 261367393 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1594342 | Douglas Murphy-Chutorian | C/O Semler Scientific, Inc. 2340-2348 Walsh Avenue, Suite 2344 Santa Clara CA 95051 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-28 | 2,000 | $2.10 | 2,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-28 | 495 | $71.43 | 1,505 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-28 | 605 | $72.33 | 900 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-28 | 600 | $73.25 | 300 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-28 | 140 | $74.07 | 160 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-28 | 160 | $74.08 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-02-28 | 2,000 | $0.00 | 2,000 | $2.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 71,000 | 2024-11-08 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 trading plan adopted by the reporting person on December 7, 2021.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.92 to $71.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $72.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.00 to $73.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
- The shares underlying the option are fully vested and immediately exercisable.
Billionaire Hedge Funds
